Clinical Trial Update: Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the long-term safety and efficacy of Plozasiran in adults with hypertriglyceridemia, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• Plozasiran

Snippet

Sponsor: Arrowhead Pharmaceuticals | Conditions: Hypertriglyceridemia | Phase 3 | Status: RECRUITING